Clinical experience analysis of liver transplantation from donation after citizen's death in 78 cases
-
摘要:
目的 总结公民逝世后器官捐献肝移植的临床经验及疗效分析。 方法 回顾性分析2012年3月至2015年11月四川大学华西医院肝脏移植中心完成的公民逝世后器官捐献供体肝移植的76例供体和78例受体的临床资料。观察肝移植受体早期移植物功能恢复情况并分析引起早期移植物功能障碍(EAD)的危险因素,观察远期的移植物生存及受体生存情况、并发症发生情况。 结果 78例受体术后EAD的发生率为36%(28/78),其中供体总胆红素(TB)高和冷缺血时间长是EAD发生的危险因素。受者围手术期存活率为92%(72/78),死亡6例,分别死于原发性移植物失功4例、上消化道大出血1例、肺部感染1例。术后发生腹腔感染5例,胆道狭窄3例,血管血栓形成2例,除1例死亡外,其余经相应治疗后好转。受体术后1年的存活率为84.2%,2年存活率为80.0%。 结论 公民逝世后器官捐献供肝是较好的供肝来源,其近远期效果良好。控制术前供肝质量,缩短冷缺血时间等均是提高临床效果的重要措施。 Abstract:Objective To summarize the clinical experience and effect analysis of liver transplantation from donation after citizen's death. Methods Clinical data of 76 donors and 78 recipients of liver transplantation from donation after citizen's death completed in Liver Transplantation Center of West China Hospital, Sichuan University from March 2012 to November 2015 were analyzed retrospectively. The functional recovery of early allografts in liver transplant recipients was observed and the risk factors causing early allograft dysfunction (EAD) were analyzed. In addition, long-term survival of allografts and recipient as well as complications was observed. Results The incidence of postoperative EAD was 36% (28/78) in 78 recipients. High total bilirubin (TB) and long cold ischemia time constituted the risk factors of EAD. Survival rate of the recipients was 92% (72/78) during perioperation, and 6 cases died, of which 4 cases died of primary graft dysfunction, 1 case of upper gastrointestinal hemorrhage and 1 case of pulmonary infection. Postoperative abdominal infection occurred in 5 cases, with biliary stricture in 3 cases and vascular thrombosis in 2 cases. One case died, and the rest were improved after corresponding treatment. The 1-year survival rate of the recipients was 84.2% and 2-year survival rate was 80% after operation. Conclusion Liver transplantation from donation after citizen's death realizes favorable short and long-term effects, which can be regarded as a good source of donor livers. Important measures such as controlling the preoperative quality of donor liver and shortening the cold ischemia time can improve the clinical effect. -
表 1 术后发生早期移植物功能障碍的危险因素分析结果
Table 1. Analysis results of risk factors for early allograft dysfunction after transplantation
危险因素 na EAD发生率[%(n/n)] P值 供体年龄 ≥50岁 17 41(7/17) 0.728 <50岁 61 34(21/61) 供体BMI ≥25 kg/m2 5 4/5 0.200 <25 kg/m2 73 33(24/73) 供体TB ≥34.2 μmol/L 10 90(9/10) 0.028 <34.2 μmol/L 68 28(19/68) 供体ICU住院时间 ≥5 d 12 33(4/12) 0.889 <5 d 66 36(24/66) 供体热缺血时间 ≥15 min 43 42(18/43) 0.400 <15 min 35 29(10/35) 供体冷缺血时间 ≥14 h 18 67(12/18) 0.046 <14 h 60 27(16/60) 受体年龄 ≥55岁 18 28(5/18) 0.565 <55岁 60 38(23/60) 受体MELD评分 ≥30 19 37(7/19) 0.946 <30 59 36(21/59) 受体手术时间 ≥10 h 14 64(9/14) 0.118 <10 h 64 30(19/64) 受体接受供肝类型 儿童供肝 20 30(6/20) 0.657 成人供肝 58 38(22/58) 注:na指供肝数量 -
[1] 刘学民, 王博, 于良, 等.心脏死亡供体经典原位肝移植的单中心临床研究[J]. 器官移植, 2013, 4(1):23-27. http://www.organtranspl.com/browse/detail/qkid/62/id/337.htmlLiu XM, Wang B, Yu L, et al. Single-center clinical study of orthotopic liver transplantation using donation after cardiac death[J]. Organ Transplant, 2013, 4(1):23-27. http://www.organtranspl.com/browse/detail/qkid/62/id/337.html [2] Olthoff KM, Kulik L, Samstein B, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors[J]. Liver Transpl,2010,16(8):943-949. doi: 10.1002/(ISSN)1527-6473 [3] 中华医学会器官移植学分会. 中国心脏死亡器官捐献工作指南(第2版)[J/CD]. 中华移植杂志(电子版), 2012, 6(3):221-224.Organ Transplantation Branch of Chinese Medical Association. Work guide of cardiac death organ donation in China (2nd edition)[J/CD]. Chin J Transplant(Electr Edit), 2012, 6(3):221-224. [4] 蓝柳根,秦科,董建辉,等. 公民逝世后器官捐献供肝移植31例临床效果分析[J].器官移植,2015,6(5):316-321. http://www.organtranspl.com/browse/detail/qkid/88/id/126.htmlLan LG, Qin K, Dong JH, et al. Clinical effect analysis of liver transplantation from donation after citizen's death in 31 cases[J]. Organ Transplant,2015,6(5):316-321. http://www.organtranspl.com/browse/detail/qkid/88/id/126.html [5] Doyle MB, Collins K, Vachharajani N, et al. Outcomes using grafts from donors after cardiac death[J]. J Am Coll Surg,2015,221(1):142-152. doi: 10.1016/j.jamcollsurg.2015.03.053 [6] Savier E, Dondero F, Vibert E, et al. First experience of liver transplantation with type 2 donation after cardiac death in France[J]. Liver Transpl, 2015,21(5):631-643. doi: 10.1002/lt.24107 [7] Firl DJ, Hashimoto K, O'Rourke C, et al. Impact of donor age in liver transplantation from donation after circulatory death donors: a decade of experience at Cleveland Clinic[J]. Liver Transpl,2015,21(12):1494-1503. doi: 10.1002/lt.24316 [8] Detry O, Deroover A, Meurisse N, et al. Donor age as a risk factor in donation after circulatory death liver transplantation in a controlled withdrawal protocol programme[J]. Br J Surg,2014,101(7):784-792. doi: 10.1002/bjs.2014.101.issue-7 [9] Singhal AK, Sheng X, Drakos SG, et al. Impact of donor cause of death on transplant outcomes: UNOS registry analysis[J].Transplant Proc, 2009,41(9):3539-3544. doi: 10.1016/j.transproceed.2009.06.192 [10] Xia W, Ke Q, Wang Y, et al. Donation after cardiac death liver transplantation: graft quality evaluation based on pretransplant liver biopsy[J]. Liver Transpl,2015,21(6):838-846. doi: 10.1002/lt.v21.6 [11] 赵强, 金倩雯, 邓雯,等. 中国二类DCD供肝移植后早期肝功能不全42例的危险因素分析[J].中华器官移植杂志, 2015, 36(5):276-279.Zhao Q, Jin QW, Deng W, et al. Risk analysis of early allograft dysfuntion after liver transplantation from 42 cases of Chinese type II organ donation[J]. Chin J Organ Transplant, 2015, 36(5):276-279. [12] Fishbein TM, Fiel MI, Emre S, et al. Use of livers with microvesicular fat safely expands the donor pool[J]. Transplantation,1997, 64(2):248-251. doi: 10.1097/00007890-199707270-00012 [13] Verran D, Kusyk T, Painter D, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation[J]. Liver Transpl, 2003,9(5):500-505. doi: 10.1053/jlts.2003.50099 [14] Frongillo F, Avolio AW, Nure E, et al. Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival[J]. Transplant Proc,2009,41(4):1268-1272. doi: 10.1016/j.transproceed.2009.03.096 [15] Gao F, Xu X, Ling Q, et al. Efficacy and safety of moderately steatotic donor liver in transplantation[J]. Hepatobiliary Pancreat Dis Int,2009,8(1):29-33. http://cn.bing.com/academic/profile?id=1601287648&encoded=0&v=paper_preview&mkt=zh-cn [16] Spitzer AL, Lao OB, Dick AA, et al. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment[J].Liver Transpl,2010,16(7):874-884. doi: 10.1002/lt.v16:7 [17] McCormack L, Dutkowski P, El-Badry AM, et al. Liver transplantation using fatty livers: always feasible?[J]. J Hepatol,2011,54(5):1055-1062. doi: 10.1016/j.jhep.2010.11.004 [18] Mateo R, Cho Y, Singh G, et al. Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data[J]. Am J Transplant,2006,6(4):791-796. doi: 10.1111/j.1600-6143.2006.01243.x [19] Lee KW, Simpkins CE, Montgomery RA, et al. Factors affecting graft survival after liver transplantation from donation after cardiac death donors[J].Transplantation,2006,82(12):1683-1688. doi: 10.1097/01.tp.0000250936.73034.98 [20] Lee DD, Singh A, Burns JM, et al. Early allograft dysfunction in liver transplantation with donation after cardiac death donors results in inferior survival[J]. Liver Transpl,2014,20(12):1447-1453. http://cn.bing.com/academic/profile?id=2002754214&encoded=0&v=paper_preview&mkt=zh-cn [21] Fondevila C, Hessheimer AJ, Flores E, et al. Applicability and results of Maastricht type 2 donation after cardiac death liver transplantation[J].Am J Transplant, 2012,12(1):162-170. doi: 10.1111/ajt.2012.12.issue-1
计量
- 文章访问数: 107
- HTML全文浏览量: 55
- PDF下载量: 6
- 被引次数: 0